日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers

RO7119929(一种口服TLR7激动剂前药)在晚期原发性或转移性肝癌患者中的首次人体I期研究

Yoo, Changhoon; Fabregat-Franco, Carles; Lin, Chia-Chi; Qvortrup, Camilla; Oh, Do-Youn; Yau, Thomas; Kim, Hyung-Don; Castet, Florian; Ponz Sarvise, Mariano; Hsu, Chiun; Rohrberg, Kristoffer Staal; Lichtenegger, Felix Sebastian; Franjkovic, Izolda; Kratochwil, Nicole A; Bessa, Juliana; Rossmann, Eva; Schwalie, Petra C; Rieder, Natascha; Pöschinger, Thomas; Sie, Christina Godfried; Dettling, Steffen; Schlenker, Ramona; Jiang, Tianyi; Dai, Congqi; Yun, Hongying; Hall, Elia; Yeo Te-Ying, Audrey; Hoves, Sabine; Cannarile, Michael A; Schiff, Christina; Sangro, Bruno

Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy

人CD34+来源的浆细胞样树突状细胞作为原代pDC的替代物及潜在的癌症免疫疗法

Giovanna Fiore,Wolfgang Weckwarth,Kerstin Paetzold,Llucia Albertí Servera,Manuela Gies,Jakob Rosenhauer,Martina Antoniolli,Sina Nassiri,Stephan Schmeing,Steffen Dettling,Bhavesh Soni,Meher Majety,Anne B Krug,Sabine Hoves,Monika Julia Wolf

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages

CD40 激动剂的功效由不同的 cDC 亚群介导,并被抑制性巨噬细胞所破坏

Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M Arnouk, Ahmed E I Hamouda, Ayla Debraekeleer, Victor Bosteels, Yvon Elkrim, Louis Boon, Sabine Hoves, Niels Vandamme, Sofie Deschoemaeker, Sophie Janssens, Abhishek

Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients

抗 CSF-1R 抗体 emactuzumab 联合 CD40 激动剂 selicrelumab 治疗晚期实体瘤患者的 Ib 期研究

Machiels, Jean-Pascal; Gomez-Roca, Carlos; Michot, Jean-Marie; Zamarin, Dmitriy; Mitchell, Tara; Catala, Gaetan; Eberst, Lauriane; Jacob, Wolfgang; Jegg, Anna-Maria; Cannarile, Michael A; Watson, Carl; Babitzki, Galina; Korski, Konstanty; Klaman, Irina; Teixeira, Priscila; Hoves, Sabine; Ries, Carola; Meneses-Lorente, Georgina; Michielin, Francesca; Christen, Randolph; Rüttinger, Dominik; Weisser, Martin; Delord, Jean-Pierre; Cassier, Philippe

The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models

肿瘤环境促进人源化小鼠模型中功能性人类肿瘤驻留浆细胞样树突状细胞

Ilona-Petra Maser, Sabine Hoves, Christa Bayer, Gordon Heidkamp, Falk Nimmerjahn, Jan Eckmann, Carola H Ries

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy

优化的肿瘤微环境抗血管生成重编程增强了 CD40 免疫疗法

Abhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, Daniela Pais-Ferreira, Philipp Mueller, Melanie Buchi, Chia-Huey Ooi, Matthias Kreuzaler, Petra Hirschmann, Alan Guichard, Natascha Rieder, Ruben Bill, Frank Herting, Yvonne Kienast, Stefan Dirnhofer, Christian Klein, Sabine Hoves, Carola

Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy

癌症免疫治疗中对肝细胞癌有反应性和难治性原位小鼠模型的表征

Carina Hage, Sabine Hoves, Mailin Ashoff, Veronika Schandl, Stefan Hört, Natascha Rieder, Christian Heichinger, Marco Berrera, Carola H Ries, Fabian Kiessling, Thomas Pöschinger

T cell-induced CSF1 promotes melanoma resistance to PD1 blockade

T细胞诱导的CSF1促进黑色素瘤对PD1阻断的耐药性

Neubert, Natalie J; Schmittnaegel, Martina; Bordry, Natacha; Nassiri, Sina; Wald, Noémie; Martignier, Christophe; Tillé, Laure; Homicsko, Krisztian; Damsky, William; Maby-El Hajjami, Hélène; Klaman, Irina; Danenberg, Esther; Ioannidou, Kalliopi; Kandalaft, Lana; Coukos, George; Hoves, Sabine; Ries, Carola H; Fuertes Marraco, Silvia A; Foukas, Periklis G; De Palma, Michele; Speiser, Daniel E

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

肿瘤相关巨噬细胞的快速激活可增强先前存在的肿瘤免疫力

Sabine Hoves, Chia-Huey Ooi, Carsten Wolter, Hadassah Sade, Stefan Bissinger, Martina Schmittnaegel, Oliver Ast, Anna M Giusti, Katharina Wartha, Valeria Runza, Wei Xu, Yvonne Kienast, Michael A Cannarile, Hyam Levitsky, Solange Romagnoli, Michele De Palma, Dominik Rüttinger, Carola H Ries

T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells

T细胞癌症疗法需要CD40-CD40L激活肿瘤坏死因子和诱导型一氧化氮合酶产生树突状细胞

Marigo, Ilaria; Zilio, Serena; Desantis, Giacomo; Mlecnik, Bernhard; Agnellini, Andrielly H R; Ugel, Stefano; Sasso, Maria Stella; Qualls, Joseph E; Kratochvill, Franz; Zanovello, Paola; Molon, Barbara; Ries, Carola H; Runza, Valeria; Hoves, Sabine; Bilocq, Amélie M; Bindea, Gabriela; Mazza, Emilia M C; Bicciato, Silvio; Galon, Jérôme; Murray, Peter J; Bronte, Vincenzo